Quick-Med Tech announces advances in patent coverage for NIMBUS ® technology

By Admin
Life Sciences Company Quick-Med Technologies Inc has announced advances in patent coverage in China, Australia, and Mexico for its novel, non-leaching...

Life Sciences Company Quick-Med Technologies Inc has announced advances in patent coverage in China, Australia, and Mexico for its novel, non-leaching NIMBUS ® antimicrobial technology.

The Australian Patent Office and the patent office of Mexico, Instituto Mexicano de la Propiedad Industrial have given the company pending patent entitled Disinfectant with Quaternary Ammonium Polymer and Copolymers in their respective jurisdictions, the news reports said.

The State Intellectual Property of the People’s Republic of China has also issued a notification to grant an invention patent for this pending patent in China.

The patents will expand the international intellectual property coverage for NIMBUS, the news reports said. NIMBUS technology includes the chemistry of antimicrobials that comprise a high charge density polycation built into the backbone of various polymers.

The new patents are the key composition of matter patents that cover the incorporation of a NIMBUS polycation into the main chain of a urethane polymer. The patents also provides protection for various claims regarding the efficacy and durability of an antimicrobial polyurethane.

Dr. William Toreki, co-inventor and Quick-Med’s Vice President of Research & Development said, “This patent adds an exciting new dimension to our NIMBUS technology.”

Quick-Med Technologies is a life sciences company engaged in developing proprietary, broad-based technologies to prevent infection and control the consumer and healthcare markets. The company commercialized its NIMBUS technology in traditional wound care products in 2009 and is also developing NIMBUS applications in other medical device areas including adhesives, foams, hydrogels, films, hydrocolloids, and catheters.


Featured Articles

Hyfe AI uses acoustic AI in its digital cough monitoring

Hyfe uses acoustic AI in its digital cough monitoring. Dr. Joe Brew, Co-Founder & CEO of Hyfe AI, tells us more about coughing technology post-COVID-19

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Digital Healthcare

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma